Confirmed Attending Companies Include:
203 Investment Partners
7 Hills Pharma LLC AbbVie, Inc. Adaptimmune Therapeutics Aegis Capital Corp. Agent Capital, LLC Agios Pharmaceuticals, Inc Aleta Biotherapeutics Ally Bridge Group Alpha Bronze Altius Strategy Consulting Amgen Apogenix AG Arix Bioscience Astellas Innovation Management LLC Astellas US LLC AstraZeneca Avillion LLP Bailard Investments Beigene, Ltd. Bellevue Asset Management AG Bellicum Pharmaceuticals, Inc. BerGenBio AS BioCentury Publications BioLineRx BioMotiv LLC BioSense Global LLC BioVersys AG Bloomberg Bloomberg Intelligence BoHe Angel Fund Boston Immune Technologies and Therapeutics, Inc. Cancer Research Institute Caprion Biosciences Inc Carpel Capital LLC Celgene Cell Design Labs Cenova Venture Cleveland Clinic Corvus Pharmaceuticals Cowen and Company Credit Suisse Securities (USA) LLC Daiichi Sankyo Dana-Farber Innovations DDF Ventures Defined Health, a Cello Health business EcoR1 Capital, LLC Edison Investment Research eFFECTOR Therapeutics, Inc. EMD Serono EP Vantage ESC Advisors eTheRNA Exactis Innovation F. Hoffmann La Roche Ltd. F1BioVentures Fraser Finance GlaxoSmithKline H.C. Wainwright & Co, Inc. HBM Partners AG Heartland Angels Helix Biopharma Hengrui Therapeutics Icell Kealex Therapeutics immatics biotechnologies GmbH Immunicum AB Independent IO Biotech ApS J&J Innovation Centre-Boston |
JMP Securities LLC
KaloBios Pharmaceuticals, Inc Ladenburg Thalmann Laidlaw & Company Lazard LEK Consulting, LLC Lightstone Ventures Lilly Asian Venture Lincoln Park Capital Loncar Investment, LLC M VENTURES MaxCyte, Inc. MD Anderson Cancer Center Mediqventures Merck Serono SA Merus N.V. Mikro Biyosistemler, Inc Mirati Therapeutics, Inc. Mitra Biotech Moffitt Cancer Center Mologen AG MPM Capital Nanobiotix Nektar New Enterprise Associates New Science Global Healthcare Fund Nextech Invest Ltd. Noble Financial Noble Life Science Partners Nouscom AG Novant Capital Group Novartis Oncology Oncology Venture Oppenheimer & Company OrbiMed Advisors, LLC OSE Immunotherapeutics Pelican Therapeutics PeptiMed Perseverance Capital Pfizer, Inc. Pioneer Investments Prevail Partners LLC PsiOxus Therapeutics Ltd Pullan Consulting Purdue Pharma Real Endpoints Remiges Ventures RXi Pharmaceuticals, Corp. Sangel Capital Corp. Scancell Limited ScienceSeed Scrip Pharma Intelligence Seva Venture Capital Singh Biotechnology, LLC Sofinnova Ventures, Inc. Taiho Ventures, LLC Takeda Pharmaceutical Company Limited The Leukemia & Lymphoma Society The University of Chicago Department of Pediatrics Timmune Biotech, Inc. Treehill Advisors LLP, UK TVM Life Science Management Inc. Venn Therapeutics, LLC Vertex Healthcare Ventures VLP Therapeutics Wasatch Advisors WBB Securities WestPark Capital ZFHN |
More to be announced....